Rhythm director granted RSUs, options and exercises RSUs
RHYTHM PHARMACEUTICALS director Stuart A. Arbuckle reported equity-based compensation and an option exercise.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
RHYTHM PHARMACEUTICALS director Stuart A. Arbuckle reported equity-based compensation and an option exercise. He received 2,324 restricted stock units (RSUs) and stock options for 3,691 shares of common stock at an exercise price of $107.55 per share, expiring on June 23, 2036. He also exercised 4,712 RSUs into 4,712 shares of common stock, bringing his direct common stock holdings to 11,712 shares. The new RSUs and options generally vest in full by June 24, 2027, subject to continued service.
Insider Trade Summary
4,712 shares exercised/converted
Exercise
4 txns
Insider
Arbuckle Stuart A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,691 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 2,324 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 4,712 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,712 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 3,691 contracts (Direct);
Restricted Stock Units — 2,324 contracts (Direct);
Common Stock — 11,712 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2. The restricted stock units are fully vested. The restricted stock units have no expiration date.
- F3. The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date.
- F4. The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.
Key Figures
RSU grant: 2,324 units
Option grant shares: 3,691 shares
Option exercise price: $107.55 per share
+3 more
6 metrics
RSU grant
2,324 units
Restricted Stock Units granted on June 24, 2026
Option grant shares
3,691 shares
Stock options granted on June 24, 2026
Option exercise price
$107.55 per share
Conversion/exercise price for stock options
Option expiration
June 23, 2036
Expiration date of newly granted stock options
RSUs exercised
4,712 units
RSUs converted into common stock on June 23, 2026
Common shares after exercise
11,712 shares
Direct common stock holdings after RSU conversion
Key Terms
Restricted Stock Units, Stock Option (right to buy), Exercise or conversion of derivative security, fully vested, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"Stock Option (right to buy) with an exercise price of 107.5500."
Exercise or conversion of derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security."
fully vested financial
"The restricted stock units are fully vested."
expiration date financial
"The options fully vest and have an expiration date of 2036-06-23."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Stuart Arbuckle receive in this RYTM Form 4 filing?
Stuart Arbuckle received 2,324 restricted stock units and stock options for 3,691 shares of Rhythm Pharmaceuticals common stock. These awards are compensation grants, not open-market purchases, and give him future rights to acquire or receive company shares under specified terms.
What is the exercise price and expiration date of Stuart Arbuckle’s new RYTM stock options?
The newly granted stock options cover 3,691 shares at an exercise price of $107.55 per share and expire on June 23, 2036. Arbuckle can choose to exercise these options after vesting, paying the exercise price to receive common shares.
What happened to the 4,712 restricted stock units mentioned in the RYTM Form 4?
The 4,712 restricted stock units were exercised and converted into 4,712 shares of common stock. Following this derivative exercise transaction, the filing shows the RSU position at zero, indicating those particular units have fully settled into common shares.
When do Stuart Arbuckle’s new Rhythm Pharmaceuticals RSUs and options vest?
The footnotes state the new RSUs and options fully vest on the earlier of June 24, 2027 or immediately before Rhythm’s next 2027 annual stockholder meeting. Vesting is conditioned on Arbuckle’s continued service with the company through the applicable vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
